Apolipoprotein d expression absence in degenerating neurons of human central nervous system

Histology and Histopathology

Volumn 23, Issue 8, 2008, Pages 995-1001

  Navarro, Ana ^a   Ordóñez, Cristina ^a   Martínez, Eva ^a   Pérez, Cristina ^a   Astudillo, Aurora ^b   Tolivia, Jorge ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Apolipoprotein D; Fluoro jade; Histochemistry; Human; Immunohistochemistry; Neurodegeneration

Indexed keywords

APOLIPOPROTEIN D; BIOLOGICAL MARKER; FLUORESCENT DYE; FLUORO JADE; ORGANIC COMPOUND;

ADULT; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM; ENZYME IMMUNOASSAY; HUMAN; METABOLISM; MIDDLE AGED; NERVE CELL; NERVE DEGENERATION; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; APOLIPOPROTEINS D; BIOLOGICAL MARKERS; CENTRAL NERVOUS SYSTEM; FLUORESCENT DYES; HUMANS; IMMUNOENZYME TECHNIQUES; MIDDLE AGED; NERVE DEGENERATION; NEURONS; ORGANIC CHEMICALS;

EID: 46249128941     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Ballok D.A., Millward J.M. and Sakic B. (2003). Neurodegeneration in autoimmune MRL-1pr mice as revealed by Fluoro Jade B staining. Brain Res. 964, 200-210.
2. Belloir B., Kovari E., Surini-Demiri M. and Savioz A. (2001). Altered apolipoprotein D expression in the brain of patients with Alzheimer disease. J. Neurosci. Res. 64, 61-69.
3. Boyles J.K., Notterpek L.M. and Anderson L.J. (1990). Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve. Identification of apolipoprotein D, apolipoprotein AIV, apolipoprotein E and apolipoprotein A-I. J. Biol. Chem. 265, 17805-17815.
4. Cammermeyer J. (1961). The importance of avoiding the "dark" neurons in experimental neuropathology. Acta Neurophatol. 1, 245-270.
5. Desai P.P., Ikonomovic M.D., Abrahamson E.E., Hamilton R.L., Isanski B.A. and Hope C.E. (2005). Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex. Neurobiol. Dis. 20, 574-582.
6. Díez-Itza I., Vizoso F., Merino A.M., Sánchez L.M., Tolivia J., Fernandez J., Rubial A. and López-Otin C. (1994). Expression and prognostic significance of apolipoprotein D in breast cancer. Am. J. Pathol. 144, 310-20.
7. Franz G., Reindl M., Patel S.C., Beer R., Unterrichter I., Berger T., Schmutzhard E., Poewe W. and Kampfl A. (1999). Increased expression of apolipoprotein D following experimental traumatic brain injury. J. Neurochem. 73, 1615-1625.
8. Gallyas F., Wolf J.R., Bottcher H. and Zaborsky L. (1980). A reliable and sensitive method to localize terminal degeneration and lysosomes in the central nervous system. Stain Technol. 55, 299-306.
9. Glöckner F. and Ohm T.G. (2003). Hippocampal apolipoprotein D level depends on braak stage and apoE genotype. Neuroscience 122, 103-110.
10. Goodrum J.F. (1993). Cholesterol synthesis in regenerating peripheral nerve is not influenced by serum cholesterol levels. J. Neurochem. 60, 1564-1566.
11. Goodrum J.F., Bouldin T.W., Zhang S.H., Maeda N. and Popko B. (1995). Nerve regeneration and cholesterol reutilization occur in the absence of apolipoproteins E and A-I in mice. J. Neurochem. 64, 408-416.
12. Hara A., Niwa M., Iwai T., Nakashima M., Bunai Y., Uematsu T., Yoshimi N. and Mori H. (1999). Neuronal apoptosis studied by a sequential TUNEL technique, a method for tract-tracing. Brain Res. Brain Res. Protoc. 4, 140-146.14.
13. Horrobin D.F. (1998). The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia. Schizophr. Res. 30, 193-208.
14. Horrobin D.F. and Bennett C.N. (1999). New gene targets related to schizophrenia and other psychiatric disorders: enzymes, binding proteins and transport proteins involved in phospholipid and fatty acid metabolism. Prostaglandins Leukot. Essent. Fatty Acids 60, 141-167.
15. Kalman J., McConathy W., Araoz C., Kasa P. and Lacko A.G. (2000). Apolipoprotein D in aging brain and in Azheimer's dementia. Neurol. Res. 22, 330-336.
16. Khan M.M., Parikh V.V. and Mahadik S.P. (2003). Antipsychotic drugs differentially modulate apolipoprotein D in rat brain. J. Neurochem. 86, 1089-1100.
17. Kiernan J.A., Macpherson C.M., Price A. and Sun T. (1998). A histochemical examination of the staining of kainate-induced neuronal degeneration by anionic dyes. Biotech. Histochemistry 73, 244-54.
18. Mytilineou C., Kramer B.C. and Yabut J.A. (2002). Glutathione depletion and oxidative stress. Parkinsonism Relat. Disord. 8, 385-387.
19. Navarro A., Tolivia J., Astudillo A. and del Valle E. (1998). Pattern of apolipoprotein D immunoreactivity in human brain. Neuros. Lett. 254, 17-20.
20. Navarro A., Tolivia J. and del Valle E. (2001). Immunohistochemical presence of apolipoprotein D in senile plaques. J. Histotechnol. 24, 45-48.
21. Navarro A., del Valle E., Astudillo A., González del Rey C. and Tolivia J., (2003). Immunohistochemical study of distribution of apolipoproteins E and D in human cerebral beta amyloid deposits. Exp. Neurol. 184, 697-704.
22. de Olmos J.S., Beltramino C.A. and de Olmos de Lorenzo S. (1994). Use of an amino-cupric-silver technique for the detection of early and semiacute neuronal degeneration caused by neurotoxicants, hypoxia, and physical trauma. Neurotoxicol. Teratol. 16, 545-561.
23. Ong W.Y., He Y., Suresh S. and Patel S.C. (1997). Differential expression of apolipoprotein D and apolipoprotein E in the kainic acid-lesioned rat hippocampus. Neuroscience 79, 359-367.
24. Ordoñez C., Navarro A., Pérez C., Astudillo A., Martínez E. and Tolivia J. (2006). Apolipoprotein D expression in substantia nigra of Parkinson disease. Histol. Histopathol. 21, 361-366.
25. Patel S.C., Asotra K., Patel Y.C., McConathy W.J., Patel R.C. and Suresh S. (1995). Astrocytes synthesize and secrete the lipophilic ligand carrier apolipoprotein D. Neuroreport 6, 653-657.
26. Provost P.R., Weech P.K., Tremblay N.M., Marcel Y.L. and Rassart E. (1990). Molecular characterization and differential mRNA tissue distribution of rabbit apolipoprotein D. J. Lipids Res. 31, 2057-2065.
27. Rassart E., Bedirian A., Do Carmo S., Guinard O., Sirois J., Terrisse L. and Milne R. (2000). Apolipoprotein D. Biochim. Biophys. Acta 1482,185-198.
28. Sánchez D., Ganfornina M. and Martínez S. (2002). Expression pattern of the lipocalin Apolipoprotein D during mouse embryogenesis. Mech. Dev. 110, 225-229.
29. Sánchez D., López-Arias B., Torroja L., Canal I., Wang X., Bastiani M.J. and Ganfornina M.D. (2006). Loss of glial lazarillo, a homolog of apolipoprotein D, reduces lifespan and stress resistance in Drosophila, Curr Biol. 16, 680-686.
30. Schmued L.C., Albertson C. and Slikker W. Jr (1997). Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res. 751, 37-46.
31. Schmued L.C. and Hopkins K.J. (2000). Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res. 874, 123-130.
32. Schmued L.C., Stowers C.C., Scallet A.C. and Xu L. (2005). Fluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neurons. Brain Res. 1035, 24-31.
33. Séguin D., Desforges M. and Rassart E. (1995). Molecular characterization and differential mRNA tissue distribution of mouse apolipoprotein D. Mol. Brain Res. 30, 242-250.
34. Spreyer P., Schaal H., Kuhn G., Rothe T., Unterbeck A., Olek K. and Müller H.W. (1990). Regeneration-associated high level expression of apolipoprotein D mRNA in endoneurial fibroblasts of peripheral nerve. Eur. Mol. Biol. Org. J. 9, 2479-2484.
35. Suresh S., Yan Z., Patel R.C., Patel Y.C. and Patel S.C. (1998). Cellular cholesterol storage in the Niemann-Pick disease type C mouse is associated with increased expression and defective processing of apolipoprotein D. J. Neurochem. 70, 242-251.
36. Terrisse L., Poirier J., Bertrand P., Merched A., Visvikis S., Siest G., Milne R. and Rassart É. (1998). Increased levels of apolipoprotein D in cerebrospinal fluid and hippocampus of Alzheimer's patients. J. Neurochem. 71, 1643-1650.
37. Thomas E.A., Dean B., Pavey G. and Sutcliffe J.G. (2001). Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the physiopathology of psychiatric disorders. Proc. Natl. Acad. Sci. USA 98, 4066-4071.
38. Thomas E.A., Dean B., Scarr E., Copolov D. and Sutcliffe J.G. (2003). Differences in neuroanatomical sites of apo D elevation discriminate between schizophrenia and bipolar disorder. Mol. Psychiatr. 8, 167-175.
39. Tolivia J., Navarro A. and Tolivia D. (1994). Differential staining of nerve cells and fibres for sections of paraffin-embedded material in mammalian central nervous system. Histochemistry 102, 101-104.
40. Tolivia J., Navarro A., del Valle E., Pérez C., Ordóñez C. and Martínez E. (2006). Application of Photoshop and Scion Image analysis to quantification of signals in histochemistry, immunocytochemistry and hybridocytochemistry. Anal. Quant. Cytol. Histol. 28:43-53.
41. del Valle E., Navarro A., Méndez E., Juárez A., Astudillo A. and Tolivia J. (2001). Could apolipoprotein D be a neuronal marker of necrobiosis?. J. Histotech. 24, 29-35.
42. del Valle E., Navarro A., Astudillo A. and Tolivia J. (2003). Apolipoprotein D expression in human brain reactive astrocytes. J. Histochem. Cytochem. 51, 1285-1290.
43. Ye X., Carp R.I., Schmued L.C. and Scallet A.C. (2001). Fluoro-Jade and silver methods: application to the neuropathology of scrapie, a transmissible spongiform encephalopathy. Brain Res. Brain Res. Protoc. 8, 104-112.